INCYTE ANNOUNCES HEALTH CANADA APPROVAL OF OPZELURA (RUXOLITINIB) CREAM FOR TREATMENT OF ATOPIC DERMATITIS (AD) AND NONSEGMENTAL VITILIGO

Reuters · 10/16 20:26

Please log in to view news